Clinical trial
Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in…
NCT00080951 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00080951 |
|---|---|
| Title | Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer |
| Official title | Phase II Trial Of Irinotecan + 5-Fluorouracil + Leucovorin + Oxaliplatin As First-Line Treatment For Metastatic Colorectal Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | fluorouracil, irinotecan hydrochloride, leucovorin calcium, oxaliplatin |
| Enrollment | 14 |
| Start date | Mar 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Feb 1, 2008 |
| First posted | Apr 8, 2004 |
| Last update posted | Dec 7, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: